Brain Tumor, Primary

specific

An aggressive malignant embryonal neoplasm arising from the central nervous system. It is composed of cells with a large eccentric nucleus, prominent nucleolus, and abundant cytoplasm. Mutations of the SMARCB1 gene or very rarely SMARCA4 (BRG1) gene are present. The vast majority of cases occur in childhood. Symptoms include lethargy, vomiting, cranial nerve palsy, headache, and hemiplegia.

18

Centers

15

Active Trials

Cancer Funding

Top Centers for Brain Tumor, Primary(18)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
56.5
2
NCI Comprehensive
Active Research Program
56.5
3
NCI Comprehensive
Active Research Program
56.5
4
NCI Clinical
Active Research Program
56.5
5
NCI Comprehensive
Active Research Program
56.5
6
Active Research Program
56.5
7
NCI Clinical
Active Research Program
56.5
8
NCI Comprehensive
Active Research Program
56.5
9
Active Research Program
56.5
1056.5
11
Active Research Program
56.5
12
Active Research Program
56.5
13
Active Research Program
56.5
14
Active Research Program
56.5
15
Active Research Program
56.5
16
NCI Comprehensive
34.0
17
NCI Comprehensive
34.0
1834.0

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →